Fuel toxicity-associated spectrum (FTAS): a unifying nomenclature for metabolic disorders
1Diabcare India Diabetes Center, CK Tower, Kavu Nagar Stop, Near Thondayad Junction, Mavoor Road, Calicut, Kerala, 673017, India. doctor@diabcareindia.com.
Abstract:
BACKGROUND: The global obesity surge has precipitated a parallel rise in diabetes, cardiovascular, kidney, and reproductive-metabolic diseases like polycystic ovarian syndrome (PCOS), creating an unsustainable healthcare burden fragmented by organ-specific nomenclature. Legacy terms like type 2 diabetes and non-alcoholic fatty liver disease (NAFLD) focus on end-stage manifestations, obscuring shared pathogenic roots. This review aimed to propose and define the Fuel Toxicity-Associated Spectrum (FTAS) as a unifying nomenclature and staging framework for adiposity-related metabolic disorders. This represents a novel conceptual synthesis building upon established pathophysiological principles. METHOD: We conducted a narrative review, synthesizing literature on the pathophysiology and nomenclature of adiposopathy associated metabolic conditions to build a logical argument for this new mechanistic classification. REVIEW FINDINGS: We propose that the FTAS framework reconceptualizes disorders from metabolic syndrome to overt organ damage as manifestations of a single pathophysiological process: chronic nutrient excess driving adipose tissue dysfunction and systemic fuel toxicity (lipotoxicity, glucotoxicity, organelle dysfunction). We provide a unifying nosology, mapping legacy diagnoses to FTAS equivalents (e.g. type 2 diabetes to FTAS-Hyperglycemia) and integrates related constructs into a hierarchical model. A novel four-stage system (Stages 0–3) was formulated, representing a hypothesis that transcending organ silos facilitates a complication-centric approach to care. The review also outlines a proposed prospective validation roadmap and a phased implementation strategy for the framework. CONCLUSION: The FTAS provides a proposed holistic, pathophysiologically grounded, and destigmatizing lexicon that unifies metabolic conditions. It aligns with modern, metabolism-targeting pharmacotherapies and is hypothesized to transform clinical practice and research by promoting early, integrated intervention, though this requires prospective validation.
Related Concept Videos
Inborn Errors of Metabolism
Bioactivation and Tissue Toxicity
Lipid Catabolism
Drug toxicity: Idiosyncratic Reactions
Toxidromes: Clinical Features
Drug Toxicity: Dose-Dependent Reactions


